Cargando…
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature
Locally advanced or metastatic renal cell carcinomas (mRCCs) account for up to 15% of all kidney cancer diagnoses. Systemic therapies (with or without surgery) represent gold standard treatments, mostly based on tyrosine kinase inhibitors in association with immunotherapy. We provide an overview of...
Autores principales: | Monti, Martina, Lunardini, Susanna, Magli, Igino Andrea, Campi, Riccardo, Primiceri, Giulia, Berardinelli, Francesco, Amparore, Daniele, Terracciano, Daniela, Lucarelli, Giuseppe, Schips, Luigi, Ferro, Matteo, Marchioni, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220270/ https://www.ncbi.nlm.nih.gov/pubmed/35740309 http://dx.doi.org/10.3390/biomedicines10061287 |
Ejemplares similares
-
Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature
por: Marchioni, Michele, et al.
Publicado: (2022) -
Editorial Comment to Randomized trials to determine the ideal management of the renal artery during partial nephrectomy: Life's under no obligation to give us what we expect
por: Campi, Riccardo, et al.
Publicado: (2021) -
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023) -
Robot-assisted laparoscopic bladder diverticulectomy and greenlight laser anatomic vaporization of the prostate
por: Cindolo, Luca, et al.
Publicado: (2018) -
Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs
por: Ferretti, Simone, et al.
Publicado: (2023)